Header Logo

Connection

Mohammed Rassool to Ethambutol

Back to Details
This is a "connection" page, showing publications Mohammed Rassool has written about Ethambutol.
Mohammed Rassool
Connection Strength
0,058
Ethambutol
  1. Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial. Lancet Infect Dis. 2024 Sep; 24(9):1003-1014.
    View in: PubMed
    Score: 0,058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.